Cormedix
CRMD
$5.41
Share price
-1.99%
Change (1 day)
5.66%
Change (1 year)
Categories
P/S ratio for Cormedix (CRMD)
P/S ratio as of May 2024 (TTM): N/A
According to Cormedix's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2023 the company had a P/S ratio of N/A.
P/S ratio history for Cormedix from 2010 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | N/A | -100% |
| 2022 | > 1000 | 193.46% |
| 2021 | 908 | -9.06% |
| 2020 | 998 | 51.3% |
| 2019 | 660 | 101.85% |
| 2018 | 327 | 219.85% |
| 2017 | 102 | -62.98% |
| 2016 | 276 | -20.56% |
| 2015 | 347 | 53.28% |
| 2014 | 227 | -97.8% |
| 2013 | > 1000 | |
| 2012 | N/A | |
| 2011 | N/A | |
| 2010 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Becton Dickinson BDX | 3.46 | N/A | 🇺🇸 USA |
 Utah Medical Products UTMD | 4.85 | N/A | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 0.0988 | N/A | 🇺🇸 USA |